Please check your internet connection and try again.
# Walethmade%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide
## Overview
Walethmade%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide is a quaternary ammonium compound with anticholinergic properties. It is thought to work by blocking muscarinic receptors.
## Primary Indications
* Gastrointestinal (GI) antispasmodic for the relief of abdominal cramps and pain.
* Urinary antispasmodic for the relief of bladder spasms.
## Adult Dosing
* **Oral:** 50 mg to 100 mg three times daily. Maximum dose not clearly established but should not exceed typical maximum anticholinergic doses to avoid excessive side effects.
* **Intramuscular/Intravenous:** 20 mg to 50 mg every 4-6 hours as needed. May require higher doses in acute settings.
Dosing may require adjustment based on specific clinical indication and patient response.
## Pediatric Dosing
Limited published pediatric dosing data is available for Walethmade%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide. Use in pediatric populations should be approached with caution and typically reserved for situations where benefits outweigh risks under expert guidance. Consult specialized pediatric resources or local protocols for guidance.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustments are established. Caution should be exercised, and lower doses may be considered due to potential accumulation.
* **Hepatic Impairment:** No specific dose adjustments are established. Caution should be exercised.
## Contraindications
* Known hypersensitivity to Walethmade%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide or other anticholinergic agents.
* Angle-closure glaucoma.
* Myasthenia gravis.
* Obstructive uropathy.
* Obstructive GI disorders (e.g., pyloric stenosis, achalasia).
* Severe ulcerative colitis or toxic megacolon.
## Adverse Effects
* **Common:** Dry mouth, blurred vision, constipation, urinary retention, drowsiness, dizziness.
* **Serious:** Tachycardia, confusion, hallucinations (particularly in elderly), heat prostration.
## Key Drug Interactions
* **Other Anticholinergics:** Additive anticholinergic effects, increasing the risk of adverse effects.
* **CNS Depressants (e.g., alcohol, benzodiazepines, opioids):** Potentiated CNS depressant effects, leading to increased drowsiness and confusion.
* **Proton Pump Inhibitors (PPIs) and H2 Blockers:** May reduce the efficacy of these agents by increasing gastric pH.
* **Amantadine:** Increased risk of anticholinergic side effects.
* **Tricyclic Antidepressants (TCAs):** Increased risk of anticholinergic side effects and potential for additive cardiac effects.
## Monitoring
* Monitor for signs and symptoms of anticholinergic toxicity (e.g., dry mouth, blurred vision, urinary retention, constipation, confusion, tachycardia).
* Assess for relief of abdominal or bladder spasms.
* Evaluate for potential drug interactions, especially in patients on multiple medications.
## Clinical Pearls
* Due to anticholinergic effects, caution is advised in elderly patients who are more susceptible to confusion and adverse events.
* May cause drowsiness; patients should be advised to avoid driving or operating heavy machinery until they know how this medication affects them.
* Adequate hydration and stool softeners may help manage constipation.
***
*This information is intended for healthcare professionals. It is crucial to consult the most current prescribing information and relevant clinical guidelines for complete and up-to-date details before making any therapeutic decisions.*
